A Genetically Engineered Human Organoid Model Reveals Distinct Genetic and Epigenetic Barriers of Lineage Plasticity in Early PDAC Transformation
Authors:
Preprint
Abstract
The lack of accurate, human-based models recapitulating early-stage pancreatic ductal adenocarcinoma (PDAC) has hindered therapeutic development. Using pluripotent stem cell-derived pancreatic progenitor organoids, we established a human PDAC model that faithfully reproduces the genetic, epigenetic, and transcriptomic trajectory of tumor initiation and progression in vitro , validated against clinical datasets and histopathology. We demonstrate that CDKN2A loss, nearly universal in patients but dispensable in mouse models, is essential for neoplastic transformation when combined with KRAS and TP53 mutations, while SMAD4 loss promotes tumor progression. Multi-omics profiling reveals epigenetic repression of pancreatic lineage program during PDAC initiation, alongside oncogenic AP-1-driven chromatin remodeling. Notably, we identify TET1 suppression as a mechanistic link between oncogenic ERK signaling and the hypermethylation and silencing of essential pancreatic transcription factors. This model captures the genetic and epigenetic determinants of human PDAC, reveals antagonism between oncogenic and lineage restriction programs, and supports TET-based lineage restoration as a promising early intervention strategy for high-risk individuals.Keywords
Funding Information
- NIH (R01DK096239)
- NIH (R01HD111256)
- NIH (P30CA008748)
- NIH (T32GM008539)
- Starr Tri-I Stem Cell Initiative (2016-032)
- Geoffrey Beene Cancer Research Center
- Shipley Foundation
- Cycle for Survival Funds
- Tri-Institutional Starr Stem Cell Scholars Fellowship
- NYSTEM training grant from the Center for Stem Cell Biology (DOH01-TRAIN3-2015-2016-00006)
- Beatrice P. K. Palestin Fellowship and a Bruce Charles Forbes Fellowship
This publication has 75 references indexed in Scilit:
- Loss of KDM6A Activates Super-Enhancers to Induce Gender-Specific Squamous-like Pancreatic Cancer and Confers Sensitivity to BET InhibitorsCancer Cell, 2018
- Response to: “The Role of Bundle Size for Preventing Surgical Site Infections after Colorectal Surgery: Is More Better?”Journal of Gastrointestinal Surgery, 2018
- Integrated Genomic Characterization of Pancreatic Ductal AdenocarcinomaCancer Cell, 2017
- Mammary-Stem-Cell-Based Somatic Mouse Models Reveal Breast Cancer Drivers Causing Cell Fate DysregulationCell Reports, 2016
- Organoid Models of Human and Mouse Ductal Pancreatic CancerCell, 2015
- Oncogenic Kras Activates a Hematopoietic-to-Epithelial IL-17 Signaling Axis in Preinvasive Pancreatic NeoplasiaCancer Cell, 2014
- The iCRISPR Platform for Rapid Genome Editing in Human Pluripotent Stem Cells2014
- Oncogenic Braf Induces Melanocyte Senescence and Melanoma in MiceCancer Cell, 2009
- Chronic Pancreatitis Is Essential for Induction of Pancreatic Ductal Adenocarcinoma by K-Ras Oncogenes in Adult MiceCancer Cell, 2007
- Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in miceCancer Cell, 2005